The cost‐effectiveness of immediate treatment or watch and wait with deferred chemotherapy for advanced asymptomatic follicular lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|180|1|52-59

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.1, 2018-01, pp. : 52-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced‐stage follicular lymphoma: A cost‐effectiveness analysis

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2637-2645

John Wiley & Sons Inc

Access to resources Recommend Favorite

A population‐based study of prognosis in advanced stage follicular lymphoma managed by watch and wait

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 435-444

John Wiley & Sons Inc

Access to resources Recommend Favorite

Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch‐and‐wait strategy after complete resection

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 4, 2018-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom

By Hart Warren Mark   Abrams Paul   Munro Vicki   Retsa Peny   Nazir Jameel  

Journal of Medical Economics, Vol. 16, Iss. 10, 2013-10 ,pp. : 1246-1254

Informa Healthcare

Access to resources Recommend Favorite

Sensitivity Analysis of Cost Factors for Various Therapy Options in the Treatment of Follicular Lymphoma

By  

Oncology Research and Treatment, Vol. 29, Iss. 6, 2006-06 ,pp. : 258-264

Karger

Access to resources Recommend Favorite